JP2022524111A5 - - Google Patents

Info

Publication number
JP2022524111A5
JP2022524111A5 JP2021553136A JP2021553136A JP2022524111A5 JP 2022524111 A5 JP2022524111 A5 JP 2022524111A5 JP 2021553136 A JP2021553136 A JP 2021553136A JP 2021553136 A JP2021553136 A JP 2021553136A JP 2022524111 A5 JP2022524111 A5 JP 2022524111A5
Authority
JP
Japan
Prior art keywords
compound according
alkyl
disease
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021553136A
Other languages
English (en)
Japanese (ja)
Other versions
JP7566765B2 (ja
JP2022524111A (ja
Filing date
Publication date
Priority claimed from GBGB1903242.4A external-priority patent/GB201903242D0/en
Application filed filed Critical
Publication of JP2022524111A publication Critical patent/JP2022524111A/ja
Publication of JP2022524111A5 publication Critical patent/JP2022524111A5/ja
Priority to JP2024173169A priority Critical patent/JP2025016465A/ja
Application granted granted Critical
Publication of JP7566765B2 publication Critical patent/JP7566765B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021553136A 2019-03-11 2020-03-11 Rar活性化のための合成レチノイド Active JP7566765B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024173169A JP2025016465A (ja) 2019-03-11 2024-10-02 Rar活性化のための合成レチノイド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1903242.4 2019-03-11
GBGB1903242.4A GB201903242D0 (en) 2019-03-11 2019-03-11 Synthetic retinoids for use in rar activation
PCT/GB2020/050607 WO2020183173A2 (en) 2019-03-11 2020-03-11 Synthetic retinoids for use in rar activation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024173169A Division JP2025016465A (ja) 2019-03-11 2024-10-02 Rar活性化のための合成レチノイド

Publications (3)

Publication Number Publication Date
JP2022524111A JP2022524111A (ja) 2022-04-27
JP2022524111A5 true JP2022524111A5 (https=) 2023-02-14
JP7566765B2 JP7566765B2 (ja) 2024-10-15

Family

ID=66380503

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021553136A Active JP7566765B2 (ja) 2019-03-11 2020-03-11 Rar活性化のための合成レチノイド
JP2024173169A Pending JP2025016465A (ja) 2019-03-11 2024-10-02 Rar活性化のための合成レチノイド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024173169A Pending JP2025016465A (ja) 2019-03-11 2024-10-02 Rar活性化のための合成レチノイド

Country Status (14)

Country Link
US (2) US12344587B2 (https=)
EP (2) EP4414355A3 (https=)
JP (2) JP7566765B2 (https=)
KR (2) KR102722925B1 (https=)
CN (2) CN113677667B (https=)
AU (1) AU2020235464B2 (https=)
BR (1) BR112021017045A2 (https=)
CA (1) CA3131108A1 (https=)
ES (1) ES2985674T3 (https=)
GB (1) GB201903242D0 (https=)
MX (1) MX2021011028A (https=)
PL (1) PL3937923T3 (https=)
SG (1) SG11202109075WA (https=)
WO (1) WO2020183173A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201903242D0 (en) * 2019-03-11 2019-04-24 Univ Durham Synthetic retinoids for use in rar activation
CN115974860B (zh) * 2022-12-15 2024-09-24 复旦大学附属中山医院 维甲酸类化合物及其制备方法和用途、含该化合物的药物组合物
GB2638262A (en) 2024-02-16 2025-08-20 Univ Durham Synthetic retinoids for use in RAR activation
GB2642547A (en) * 2024-07-12 2026-01-14 Univ Durham Compounds for use in senotherapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149705A (en) 1987-03-13 1992-09-22 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a tetralin group and having retinoid like activity
ATE68486T1 (de) * 1988-07-28 1991-11-15 Uriach & Cia Sa J 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
JP2003081834A (ja) * 2001-09-10 2003-03-19 Shiseido Co Ltd ざ瘡治療剤、及びざ瘡治療用皮膚外用剤
RU2010136954A (ru) * 2008-02-06 2012-03-20 Носсира С.А. (Es) Фенилпрениловые производные морского и синтетического происхождения для лечения нарушения познавательной способности, нейродегенеративных или нервных заболеваний или нарушений
CN107176945B (zh) 2016-03-11 2021-06-08 中国科学院上海有机化学研究所 一种视黄酸类化合物、其制备方法、中间体及应用
WO2017152725A1 (zh) * 2016-03-11 2017-09-14 中国科学院上海有机化学研究所 一种视黄酸类化合物、其制备方法、中间体及应用
WO2017174999A1 (en) * 2016-04-07 2017-10-12 High Force Research Limited Synthetic retinoids for use in rar mediated conditions
GB201903242D0 (en) * 2019-03-11 2019-04-24 Univ Durham Synthetic retinoids for use in rar activation

Similar Documents

Publication Publication Date Title
JP2022524111A5 (https=)
KR101294014B1 (ko) 모노아민 재흡수 저해제로서의 시클로알킬아민
JP6089045B2 (ja) 痛みの緩和または治療に使用するためのフェニルカルバメート化合物
US20200179336A1 (en) Methods of treating neurological and psychiatric disorders
JP2010522709A5 (https=)
EP3349581A1 (en) Hepatitis b core protein modulators
JPH08508741A (ja) 虚血および関連疾患の処置におけるヘテロ環誘導体類
JP6215971B2 (ja) てんかん又はてんかん−関連症侯群の予防又は治療用フェニルアルキルカルバメート化合物{phenylalkylcarbamatecompoundsforuseinpreventingortreatingepilepsyorepilepsy−relatedsyndrome}
WO1996018608A1 (en) Aniline derivatives having nitrogen monoxide synthase inhibitory activity
DE69613349T2 (de) 2-aminoindane als selektive dopamin d3 liganden
JP2010522711A5 (https=)
JP2017518355A5 (https=)
KR20120022927A (ko) 레티놀 결합 단백질 4 (rbp4)에 대한 레티놀 결합을 조절하기 위한 조성물 및 방법
JP2010519287A (ja) α−ハロシクロプロピルカルボキシ化合物およびα−アルキルシクロプロピルカルボキシ化合物ならびにそれらの使用
JP2008518913A (ja) 代謝調節型グルタミン酸受容体のピリミジン及びキノリン増強因子
JP2020504165A5 (https=)
JP2005511625A5 (https=)
JPWO2010055911A1 (ja) ビフェニルアセトアミド誘導体
JP7765613B2 (ja) 新規化合物及びその情緒行動障害の治療用途
KR102560630B1 (ko) 신규 화합물 및 이의 정서행동장애 치료 용도
JPH06500097A (ja) 5−(2−クロロ−1−ヒドロキシエチル)−4−メチルチアゾール含有の医薬製剤
JP2016540756A (ja) 筋障害及び疼痛の治療並びに痙直(spasticity)及び振戦の制御に有用なベンズアミド誘導体
JP2012001537A (ja) ビフェニルアセトアミド誘導体からなる医薬
EP2818467A1 (en) Multi-target drug compounds for the treatment of neurodegenerative disorders
KR19990044479A (ko) 4-(시클로알킬)피페리딘 유도체와 4-(시클로알킬알킬)피페리딘유도체,그것들의 제법 및 치료학적 사용